Holen Sie sich die Stockscreener-App
4.98
4.18%
0.20
Cellectar Biosciences Inc Aktie (CLRB) Neueste Nachrichten
Can Cellectar Biosciences Inc. expand its profit marginsPortfolio Return Report & AI Optimized Trading Strategy Guides - khodrobank.com
How does Cellectar Biosciences Inc. compare to its peers2025 AllTime Highs & Reliable Volume Spike Trade Alerts - khodrobank.com
Is it time to cut losses on Cellectar Biosciences Inc.Market Trend Review & Weekly Momentum Stock Picks - Newser
Will Cellectar Biosciences Inc. see short term momentumOptions Play & Advanced Swing Trade Entry Plans - Newser
Is Cellectar Biosciences Inc. a strong candidate for buy and hold - khodrobank.com
Using AI based signals to follow Cellectar Biosciences Inc.July 2025 Drop Watch & Accurate Intraday Trading Signals - Newser
Real time social sentiment graph for Cellectar Biosciences Inc.2025 Institutional Moves & Community Consensus Picks - Newser
Does Cellectar Biosciences Inc. show high probability of reboundQuarterly Earnings Summary & Weekly Sector Rotation Insights - Newser
How to use a screener to detect Cellectar Biosciences Inc. breakouts2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
How moving averages guide Cellectar Biosciences Inc. trading2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Measuring Cellectar Biosciences Inc.’s beta against major indices2025 Market Sentiment & Free Community Supported Trade Ideas - Newser
Cellectar Biosciences shares fall 1.24% premarket as Oncolytics Biotech Inc. gains FDA approval for breakthrough therapies. - AInvest
Cellectar Biosciences Announces Poster Presentation at AACR Conference on Preclinical Data for Novel Cancer Treatment CLR 121225 - Quiver Quantitative
Cellectar Biosciences Presents Data on CLR 121225 in Poster Presentation at AACR Special Conference on Pancreatic Cancer Research - AInvest
Cellectar Biosciences to Present Data in Poster - GlobeNewswire
Novel Pancreatic Cancer Radio-Conjugate: Cellectar to Present Breakthrough Treatment Data at AACR Conference - Stock Titan
Analyzing drawdowns of Cellectar Biosciences Inc. with statistical toolsJuly 2025 Levels & Reliable Momentum Entry Alerts - Newser
What indicators show strength in Cellectar Biosciences Inc.2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - Newser
How to use Fibonacci retracement on Cellectar Biosciences Inc.July 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Identifying reversal signals in Cellectar Biosciences Inc.July 2025 Analyst Calls & High Accuracy Trade Alerts - Newser
Statistical indicators supporting Cellectar Biosciences Inc.’s strengthJuly 2025 Update & High Accuracy Swing Entry Alerts - Newser
Aug Macro: How does Cellectar Biosciences Inc. compare to its peersPortfolio Growth Summary & Weekly Chart Analysis and Guides - khodrobank.com
Cellectar Biosciences Inc. stock momentum explainedQuarterly Performance Summary & Daily Chart Pattern Signals - Newser
What is Cellectar Biosciences Inc. s revenue forecast2025 Trading Volume Trends & Fast Moving Stock Trade Plans - khodrobank.com
Why Cellectar Biosciences Inc. stock attracts strong analyst attentionTrade Ideas & Real-Time Price Movement Reports - Newser
Is Cellectar Biosciences Inc. trending in predictive chart modelsEarnings Beat & Weekly High Conviction Trade Ideas - Newser
Cellectar Biosciences shares fall 1.45% after-hours as Oncolytics Biotech Inc. gains regulatory momentum. - AInvest
Building trade automation scripts for Cellectar Biosciences Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Is Cellectar Biosciences Inc. vulnerable to short sellers2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Using fundamentals and technicals on Cellectar Biosciences Inc.Weekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - The Ritz Herald
Is Cellectar Biosciences Inc. part of any ETF2025 Support & Resistance & Technical Pattern Recognition Alerts - khodrobank.com
Earnings Recap: Is Cellectar Biosciences Inc. vulnerable to short sellersRate Hike & Target Return Focused Stock Picks - khodrobank.com
Will Cellectar Biosciences Inc. outperform during market ralliesEarnings Recap Summary & Community Trade Idea Sharing Platform - khodrobank.com
Is Cellectar Biosciences Inc. backed by strong institutional buyingQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - khodrobank.com
What is Cellectar Biosciences Inc. s debt to equity ratioQuarterly Market Review & AI Enhanced Trading Signals - خودرو بانک
Short interest data insights for Cellectar Biosciences Inc.Jobs Report & High Accuracy Swing Entry Alerts - Newser
Visualizing Cellectar Biosciences Inc. stock with heatmapsWeekly Trade Recap & Precise Buy Zone Identification - Newser
Cellectar Biosciences Earnings Call: Progress Amid Challenges - TipRanks
Certain Pre-Funded Warrants of Cellectar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 1-SEP-2025. - MarketScreener
Certain Warrants of Cellectar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 1-SEP-2025. - MarketScreener
Certain Stock Options of Cellectar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 1-SEP-2025. - MarketScreener
Visual analytics tools that track Akoya Biosciences Inc. performanceJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
How to manage a losing position in Cellectar Biosciences Inc.Weekly Market Report & High Accuracy Investment Signals - Newser
How sentiment analysis helps forecast Cellectar Biosciences Inc.2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):